Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.

Srivastava K, Pickard A, Craig SG, Quinn GP, Lambe SM, James JA, McDade SS, McCance DJ.

Clin Cancer Res. 2018 Aug 15;24(16):3917-3927. doi: 10.1158/1078-0432.CCR-17-3775. Epub 2018 May 8.

PMID:
29739791
2.

Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT.

Haak BW, Littmann ER, Chaubard JL, Pickard AJ, Fontana E, Adhi F, Gyaltshen Y, Ling L, Morjaria SM, Peled JU, van den Brink MR, Geyer AI, Cross JR, Pamer EG, Taur Y.

Blood. 2018 Jun 28;131(26):2978-2986. doi: 10.1182/blood-2018-01-828996. Epub 2018 Apr 19.

PMID:
29674425
3.

Corrigendum: Commensal bacteria make GPCR ligands that mimic human signalling molecules.

Cohen LJ, Esterhazy D, Kim SH, Lemetre C, Aguilar RR, Gordon EA, Pickard AJ, Cross JR, Emiliano AB, Han SM, Chu J, Vila-Farres X, Kaplitt J, Rogoz A, Calle PY, Hunter C, Bitok JK, Brady SF.

Nature. 2018 Apr 4;556(7699):135. doi: 10.1038/nature25997.

PMID:
29620727
4.

Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice.

Staffas A, Burgos da Silva M, Slingerland AE, Lazrak A, Bare CJ, Holman CD, Docampo MD, Shono Y, Durham B, Pickard AJ, Cross JR, Stein-Thoeringer C, Velardi E, Tsai JJ, Jahn L, Jay H, Lieberman S, Smith OM, Pamer EG, Peled JU, Cohen DE, Jenq RR, van den Brink MRM.

Cell Host Microbe. 2018 Apr 11;23(4):447-457.e4. doi: 10.1016/j.chom.2018.03.002. Epub 2018 Mar 22.

PMID:
29576480
5.

Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice.

Zueger PM, Holmes HM, Calip GS, Qato DM, Pickard AS, Lee TA.

J Am Geriatr Soc. 2018 May;66(5):937-944. doi: 10.1111/jgs.15328. Epub 2018 Mar 6.

PMID:
29509282
6.

Predicting Acute Exacerbations in Chronic Obstructive Pulmonary Disease.

Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA.

J Manag Care Spec Pharm. 2018 Mar;24(3):265-279. doi: 10.18553/jmcp.2018.24.3.265.

7.

3L, 5L, What the L? A NICE Conundrum.

Devlin N, Brazier J, Pickard AS, Stolk E.

Pharmacoeconomics. 2018 Jun;36(6):637-640. doi: 10.1007/s40273-018-0622-9. No abstract available. Erratum in: Pharmacoeconomics. 2018 May 10;:.

8.

Comparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers.

Schumock GT, Pickard AS.

J Comp Eff Res. 2018 Feb;7(2):177-180. doi: 10.2217/cer-2017-0057. Epub 2018 Feb 21.

9.

Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation.

Devine EB, Perfetto E, Pickard AS, Schumock GT, Segal JB, Cannon E, Gagnon JP, Brixner DI, Garrison LP, Murray MD.

J Comp Eff Res. 2018 Feb;7(2):167-175. doi: 10.2217/cer-2017-0059. Epub 2018 Feb 21.

10.

EQ-5D-Y for the assessment of health-related quality of life among Taiwanese youth with mild-to-moderate chronic kidney disease.

Hsu CN, Lin HW, Pickard AS, Tain YL.

Int J Qual Health Care. 2018 May 1;30(4):298-305. doi: 10.1093/intqhc/mzy011.

PMID:
29447362
11.

Lifestyle-related attitudes: do they explain self-rated health and life-satisfaction?

Pickard AS, Jalundhwala YJ, Bewsher H, Sharp LK, Walton SM, Schumock GT, Caskey RN.

Qual Life Res. 2018 May;27(5):1227-1235. doi: 10.1007/s11136-017-1774-3. Epub 2018 Jan 4.

PMID:
29302851
12.

Patient Experience-based Value Sets: Are They Stable?

Pickard AS, Hung YT, Lin FJ, Lee TA.

Med Care. 2017 Nov;55(11):979-984. doi: 10.1097/MLR.0000000000000802.

PMID:
29028757
13.

Commensal bacteria make GPCR ligands that mimic human signalling molecules.

Cohen LJ, Esterhazy D, Kim SH, Lemetre C, Aguilar RR, Gordon EA, Pickard AJ, Cross JR, Emiliano AB, Han SM, Chu J, Vila-Farres X, Kaplitt J, Rogoz A, Calle PY, Hunter C, Bitok JK, Brady SF.

Nature. 2017 Sep 7;549(7670):48-53. doi: 10.1038/nature23874. Epub 2017 Aug 30. Erratum in: Nature. 2018 Apr 4;556(7699):135.

14.

Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β2-Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid.

Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA.

Ann Pharmacother. 2017 Nov;51(11):945-953. doi: 10.1177/1060028017719716. Epub 2017 Jul 5.

PMID:
28677404
15.

The societal cost of heroin use disorder in the United States.

Jiang R, Lee I, Lee TA, Pickard AS.

PLoS One. 2017 May 30;12(5):e0177323. doi: 10.1371/journal.pone.0177323. eCollection 2017.

16.

The IGF axis in HPV associated cancers.

Pickard A, Durzynska J, McCance DJ, Barton ER.

Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:67-77. doi: 10.1016/j.mrrev.2017.01.002. Epub 2017 Feb 4. Review.

PMID:
28528691
17.

Choice Blindness and Health-State Choices among Adolescents and Adults.

Law EH, Pickard AL, Kaczynski A, Pickard AS.

Med Decis Making. 2017 Aug;37(6):680-687. doi: 10.1177/0272989X17700847. Epub 2017 Apr 5.

PMID:
28380316
18.

Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS, Rowen D, Street DJ, Velikova G, Young TA, King MT.

Qual Life Res. 2017 Aug;26(8):2247-2248. doi: 10.1007/s11136-017-1546-0. No abstract available.

PMID:
28337638
19.

Comparative Effectiveness of Long-Acting Beta2 -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease.

Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA.

Pharmacotherapy. 2017 Apr;37(4):447-455. doi: 10.1002/phar.1913.

PMID:
28226405
20.

Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment.

Pickard AS, Huynh L, Ivanova JI, Totev T, Graham S, Mühlbacher AC, Roy A, Duh MS.

J Patient Rep Outcomes. 2017;2(1):13. doi: 10.1186/s41687-018-0032-y. Epub 2018 Mar 1.

21.

Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment.

Norman R, Kemmler G, Viney R, Pickard AS, Gamper E, Holzner B, Nerich V, King M.

Value Health. 2016 Dec;19(8):1033-1038. doi: 10.1016/j.jval.2016.07.003. Epub 2016 Sep 21.

22.

Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale.

Krabbe PFM, Stolk EA, Devlin NJ, Xie F, Quik EH, Pickard AS.

Eur J Health Econ. 2017 Nov;18(8):967-977. doi: 10.1007/s10198-016-0841-y. Epub 2016 Nov 2.

23.
24.

Engaging Patients and Caregivers to Design Transitional Care Management Services at a Minority Serving Institution.

Ursan ID, Krishnan JA, Pickard AS, Calhoun E, DiDomenico R, Prieto-Centurion V, Sullivan JB, Valentino L, Williams MV, Joo M.

J Health Care Poor Underserved. 2016;27(1):352-365.

PMID:
27763474
25.

Transforming Latent Utilities to Health Utilities: East Does Not Meet West.

Xie F, Pullenayegum E, Pickard AS, Ramos Goñi JM, Jo MW, Igarashi A.

Health Econ. 2017 Dec;26(12):1524-1533. doi: 10.1002/hec.3444. Epub 2016 Oct 16.

PMID:
27747973
26.

EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.

Pickard AS, Gooderham M, Hartz S, Nicolay C.

J Med Econ. 2017 Jan;20(1):19-27. Epub 2016 Aug 15.

PMID:
27471948
27.

Histone Methylation by Temozolomide; A Classic DNA Methylating Anticancer Drug.

Wang T, Pickard AJ, Gallo JM.

Anticancer Res. 2016 Jul;36(7):3289-99.

28.

Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.

Melzer AC, Feemster LC, Crothers K, Carson SS, Gillespie SE, Henderson AG, Krishnan JA, Lindenauer PK, McBurnie MA, Mularski RA, Naureckas ET, Pickard AS, Au DH; COPD Outcomes-based Network for Clinical Effectiveness and Research Translation Consortium.

Ann Am Thorac Soc. 2016 Sep;13(9):1490-6. doi: 10.1513/AnnalsATS.201601-075OC.

29.

Comparative Use of a Caribbean Mesophotic Coral Ecosystem and Association with Fish Spawning Aggregations by Three Species of Shark.

Pickard AE, Vaudo JJ, Wetherbee BM, Nemeth RS, Blondeau JB, Kadison EA, Shivji MS.

PLoS One. 2016 May 4;11(5):e0151221. doi: 10.1371/journal.pone.0151221. eCollection 2016.

30.

Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DS, Fayers PM, Kemmler G, Peacock S, Pickard AS, Rowen D, Street DJ, Velikova G, Young TA, King MT.

Qual Life Res. 2016 Sep;25(9):2401. No abstract available.

PMID:
27060090
31.

Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.

Qual Life Res. 2016 Oct;25(10):2683. doi: 10.1007/s11136-016-1260-3. No abstract available.

PMID:
27060088
32.

Using Patient-reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of Cancer.

Pickard AS, Jiang R, Lin HW, Rosenbloom S, Cella D.

Clin Ther. 2016 Apr;38(4):769-77. doi: 10.1016/j.clinthera.2016.03.009. Epub 2016 Apr 1.

PMID:
27041407
33.

QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

King MT, Costa DS, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.

Qual Life Res. 2016 Mar;25(3):625-36. doi: 10.1007/s11136-015-1217-y. Epub 2016 Jan 20. Erratum in: Qual Life Res. 2016 Oct;25(10 ):2683.

34.

Maintaining a Healthy Balance: Targeting TERT to Stem Benign Prostatic Hyperplasia.

Pickard A, Mills IG.

Eur Urol. 2016 Apr;69(4):555-556. doi: 10.1016/j.eururo.2015.10.028. Epub 2015 Oct 28. No abstract available.

PMID:
26520704
35.

Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease.

Saraf SL, Oh AL, Patel PR, Jalundhwala Y, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Hassan J, Peace D, Quigley JG, Khan I, Molokie RE, Hsu LL, Mahmud N, Levinson DJ, Pickard AS, Garcia JG, Gordeuk VR, Rondelli D.

Biol Blood Marrow Transplant. 2016 Mar;22(3):441-8. doi: 10.1016/j.bbmt.2015.08.036. Epub 2015 Sep 5.

36.

Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DS, Fayers PM, Kemmler G, Peacock S, Pickard AS, Rowen D, Street DJ, Velikova G, Young TA, King MT.

Qual Life Res. 2016 Mar;25(3):637-49. doi: 10.1007/s11136-015-1115-3. Epub 2015 Sep 5. Erratum in: Qual Life Res. 2016 Sep;25(9):2401. Qual Life Res. 2017 Mar 23;:.

PMID:
26342928
37.

Using linked electronic data to validate algorithms for health outcomes in administrative databases.

Lee WJ, Lee TA, Pickard AS, Shoaibi A, Schumock GT.

J Comp Eff Res. 2015 Aug;4(4):359-66. doi: 10.2217/cer.15.14.

PMID:
26274797
38.

Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics.

de Angelis MH, Nicholson G, Selloum M, White J, Morgan H, Ramirez-Solis R, Sorg T, Wells S, Fuchs H, Fray M, Adams DJ, Adams NC, Adler T, Aguilar-Pimentel A, Ali-Hadji D, Amann G, André P, Atkins S, Auburtin A, Ayadi A, Becker J, Becker L, Bedu E, Bekeredjian R, Birling MC, Blake A, Bottomley J, Bowl M, Brault V, Busch DH, Bussell JN, Calzada-Wack J, Cater H, Champy MF, Charles P, Chevalier C, Chiani F, Codner GF, Combe R, Cox R, Dalloneau E, Dierich A, Di Fenza A, Doe B, Duchon A, Eickelberg O, Esapa CT, El Fertak L, Feigel T, Emelyanova I, Estabel J, Favor J, Flenniken A, Gambadoro A, Garrett L, Gates H, Gerdin AK, Gkoutos G, Greenaway S, Glasl L, Goetz P, Da Cruz IG, Götz A, Graw J, Guimond A, Hans W, Hicks G, Hölter SM, Höfler H, Hancock JM, Hoehndorf R, Hough T, Houghton R, Hurt A, Ivandic B, Jacobs H, Jacquot S, Jones N, Karp NA, Katus HA, Kitchen S, Klein-Rodewald T, Klingenspor M, Klopstock T, Lalanne V, Leblanc S, Lengger C, le Marchand E, Ludwig T, Lux A, McKerlie C, Maier H, Mandel JL, Marschall S, Mark M, Melvin DG, Meziane H, Micklich K, Mittelhauser C, Monassier L, Moulaert D, Muller S, Naton B, Neff F, Nolan PM, Nutter LM, Ollert M, Pavlovic G, Pellegata NS, Peter E, Petit-Demoulière B, Pickard A, Podrini C, Potter P, Pouilly L, Puk O, Richardson D, Rousseau S, Quintanilla-Fend L, Quwailid MM, Racz I, Rathkolb B, Riet F, Rossant J, Roux M, Rozman J, Ryder E, Salisbury J, Santos L, Schäble KH, Schiller E, Schrewe A, Schulz H, Steinkamp R, Simon M, Stewart M, Stöger C, Stöger T, Sun M, Sunter D, Teboul L, Tilly I, Tocchini-Valentini GP, Tost M, Treise I, Vasseur L, Velot E, Vogt-Weisenhorn D, Wagner C, Walling A, Weber B, Wendling O, Westerberg H, Willershäuser M, Wolf E, Wolter A, Wood J, Wurst W, Yildirim AÖ, Zeh R, Zimmer A, Zimprich A; EUMODIC Consortium, Holmes C, Steel KP, Herault Y, Gailus-Durner V, Mallon AM, Brown SD.

Nat Genet. 2015 Sep;47(9):969-978. doi: 10.1038/ng.3360. Epub 2015 Jul 27.

39.

HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures.

Pickard A, McDade SS, McFarland M, McCluggage WG, Wheeler CM, McCance DJ.

PLoS Pathog. 2015 Jun 24;11(6):e1004988. doi: 10.1371/journal.ppat.1004988. eCollection 2015 Jun.

40.

A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE).

Xie F, Pickard AS, Krabbe PF, Revicki D, Viney R, Devlin N, Feeny D.

Pharmacoeconomics. 2015 Aug;33(8):867-77. doi: 10.1007/s40273-015-0292-9.

41.

p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling.

Srivastava K, Pickard A, McDade S, McCance DJ.

Oncotarget. 2017 Mar 7;8(10):16202-16219. doi: 10.18632/oncotarget.3892.

42.

Synthesis, reactivity, and biological activity of gold(I) complexes modified with thiourea-functionalized tyrosine kinase inhibitors.

Yang M, Pickard AJ, Qiao X, Gueble MJ, Day CS, Kucera GL, Bierbach U.

Inorg Chem. 2015 Apr 6;54(7):3316-24. doi: 10.1021/ic502998a. Epub 2015 Mar 20.

43.

IGF-Binding Protein 2 - Oncogene or Tumor Suppressor?

Pickard A, McCance DJ.

Front Endocrinol (Lausanne). 2015 Feb 27;6:25. doi: 10.3389/fendo.2015.00025. eCollection 2015. Review.

44.

Transporting mouse embryos and germplasm as frozen or unfrozen materials.

Kenyon J, Guan M, Bogani D, Marschall S, Raspa M, Pickard A, Takeo T, Nakagata N, Fray M.

Curr Protoc Mouse Biol. 2014 Jun 16;4(2):47-65. doi: 10.1002/9780470942390.mo140064.

PMID:
25723918
45.
46.

Is it time to update societal value sets for preference-based measures of health?

Pickard AS.

Pharmacoeconomics. 2015 Mar;33(3):191-2. doi: 10.1007/s40273-015-0253-3. No abstract available.

PMID:
25586758
47.

Do health preferences contradict ordering of EQ-5D labels?

Craig BM, Pickard AS, Rand-Hendriksen K.

Qual Life Res. 2015 Jul;24(7):1759-65. doi: 10.1007/s11136-014-0897-z. Epub 2014 Dec 18.

48.

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.

Golicki D, Niewada M, Karlińska A, Buczek J, Kobayashi A, Janssen MF, Pickard AS.

Qual Life Res. 2015 Jun;24(6):1555-63. doi: 10.1007/s11136-014-0873-7. Epub 2014 Nov 26.

49.

Inhaled Anticholinergics and Risk for Acute Urinary Retention: A Case-Crossover and Case-Time-Control Study.

Lin FJ, Joo MJ, Pickard AS, Dilokthornsakul P, Lee TA.

Value Health. 2014 Nov;17(7):A776. doi: 10.1016/j.jval.2014.08.350. Epub 2014 Oct 26. No abstract available.

50.

Validity of the Eq-5d-5l in Stroke Patients.

Golicki D, Niewada M, Buczek J, Karlinska A, Kobayashi A, Janssen MF, Pickard AS.

Value Health. 2014 Nov;17(7):A570. doi: 10.1016/j.jval.2014.08.1906. Epub 2014 Oct 26. No abstract available.

Supplemental Content

Loading ...
Support Center